This phase II trial compares the effect of two different doses of stereotactic body radiation therapy (SBRT) to external beam radiation therapy (EBRT) for treating pain in patients with cancer that has spread from where it started (primary site) to the spine (metastatic). SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells and alleviate pain with fewer doses over a shorter period and cause less damage to normal tissue.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT05617716.
PRIMARY OBJECTIVE:
I. 3-month freedom from pain, defined as pain freedom at 3-months following treatment (two-fraction spine SBRT, one-fraction spine SBRT, or EBRT) per the Brief Pain Inventory.
SECONDARY OBJECTIVES:
I. 6-month freedom from pain, defined as pain freedom at 6-months following treatment per the Brief Pain Inventory.
II. 6-month local control, defined as an actuarial 6-month rate of any new, recurrent or progressing (as defined by Spine Response Assessment in Neuro-Oncology [SPINO] criteria) tumor within the planning target volume on any post-treatment magnetic resonance imaging (MRI) by 6 months.
III. 6-month vertebral compression fracture rate, assessed by post-treatment MRI by 6 months.
IV. 6-month overall survival.
V. 12-month vertebral compression fracture rate, assessed by post-treatment MRI at 12 months.
VI. Demographic disparities (by race, ethnicity, gender identity, sexual orientation, insurance status) in spine SBRT access and outcomes at 3 months.
VII. Demographic disparities (by race, ethnicity, gender identity, sexual orientation, insurance status) in spine SBRT access and outcomes at 6 months.
OUTLINE: Patients are randomized to 1 of 3 arms.
ARM I: Patients undergo two treatments of SBRT on study. Patients undergo MRI every 3-months for 12 months on study.
ARM II: Patients undergo one treatment of SBRT on study. Patients undergo MRI every 3-months for 12 months on study.
ARM II: Patients undergo one treatment of EBRT on study. Patients undergo MRI every 3-months for 12 months on study.
Lead OrganizationUniversity of Oklahoma Health Sciences Center
Principal InvestigatorShearwood McClelland